BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25261198)

  • 1. The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs.
    Schaller M; Vogel M; Kentouche K; Lämmle B; Kremer Hovinga JA
    Blood; 2014 Nov; 124(23):3469-79. PubMed ID: 25261198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.
    Luken BM; Kaijen PH; Turenhout EA; Kremer Hovinga JA; van Mourik JA; Fijnheer R; Voorberg J
    J Thromb Haemost; 2006 Nov; 4(11):2355-64. PubMed ID: 16898953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
    Thomas MR; de Groot R; Scully MA; Crawley JT
    EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Pos W; Luken BM; Kremer Hovinga JA; Turenhout EA; Scheiflinger F; Dong JF; Fijnheer R; Voorberg J
    J Thromb Haemost; 2009 Mar; 7(3):421-8. PubMed ID: 19054323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].
    Matsumoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):95-103. PubMed ID: 23629429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
    Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
    Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
    Ferrari S; Palavra K; Gruber B; Kremer Hovinga JA; Knöbl P; Caron C; Cromwell C; Aledort L; Plaimauer B; Turecek PL; Rottensteiner H; Scheiflinger F
    Haematologica; 2014 Apr; 99(4):779-87. PubMed ID: 24241492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M
    Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.
    Lotta LA; Valsecchi C; Pontiggia S; Mancini I; Cannavò A; Artoni A; Mikovic D; Meloni G; Peyvandi F
    J Thromb Haemost; 2014; 12(3):329-36. PubMed ID: 24354764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura.
    Pos W; Luken BM; Sorvillo N; Kremer Hovinga JA; Voorberg J
    J Thromb Haemost; 2011 Jul; 9(7):1285-91. PubMed ID: 21535387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Jian C; Xiao J; Gong L; Skipwith CG; Jin SY; Kwaan HC; Zheng XL
    Blood; 2012 Apr; 119(16):3836-43. PubMed ID: 22289888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
    Tsai HM; Raoufi M; Zhou W; Guinto E; Grafos N; Ranzurmal S; Greenfield RS; Rand JH
    Thromb Haemost; 2006 May; 95(5):886-92. PubMed ID: 16676082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.
    Li D; Xiao J; Paessler M; Zheng XL
    Thromb Haemost; 2011 Nov; 106(5):947-58. PubMed ID: 21901237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
    Edgar CE; Terrell DR; Vesely SK; Wren JD; Dozmorov IM; Niewold TB; Brown M; Zhou F; Frank MB; Merrill JT; Kremer Hovinga JA; Lämmle B; James JA; George JN; Farris AD
    PLoS One; 2015; 10(2):e0117614. PubMed ID: 25671313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.
    Zheng XL; Wu HM; Shang D; Falls E; Skipwith CG; Cataland SR; Bennett CL; Kwaan HC
    Haematologica; 2010 Sep; 95(9):1555-62. PubMed ID: 20378566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response.
    Schaller M; Studt JD; Voorberg J; Kremer Hovinga JA
    Hamostaseologie; 2013 May; 33(2):121-30. PubMed ID: 23443151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro.
    Ostertag EM; Kacir S; Thiboutot M; Gulendran G; Zheng XL; Cines DB; Siegel DL
    Transfusion; 2016 Jul; 56(7):1763-74. PubMed ID: 27040144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins.
    Studt JD; Kremer Hovinga JA; Radonic R; Gasparovic V; Ivanovic D; Merkler M; Wirthmueller U; Dahinden C; Furlan M; Lämmle B
    Blood; 2004 Jun; 103(11):4195-7. PubMed ID: 14982879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura.
    Feys HB; Vandeputte N; Palla R; Peyvandi F; Peerlinck K; Deckmyn H; Lijnen HR; Vanhoorelbeke K
    J Thromb Haemost; 2010 Sep; 8(9):2053-62. PubMed ID: 20553378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.